Financial Results and Trends
Revenue decreased by approximately 11.7% to $2,592,596 in the year ended March 31, 2014 as compared to $2,937,276 in the year ended March 31, 2013. In fiscal 2014, we experienced a decline in revenues as a result of an internal re-organization that took place in Europe and the longer than expected time needed to finalize the SmileMe Mirror. The launch was forecasted for the end of the calendar year 2013 but was postponed to June 2014.
Our net income/( loss) attributable to our stockholders was $0.03 for fiscal 2014 and ($0.05) for fiscal 2013. During the year ended March 31, 2014 we recognized $156,620 in equity income from our Asian investment compared to $349,054 at March 31, 2013. Our net income for fiscal 2014 was positively impacted by a gain of $1,582,597 on the sale of shares of our Glamsmile Asian Division (thereby reducing our participation from 29.4% to 21.5% at the end of January 31, 2014) compared to a net income for fiscal 2013 of a gain of $454,430 on the sale of our OTC division.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM